Evidence map›Paper›PMID 31645347›Full record

ArticleCold Spring Harbor molecular case studies2019

Ewing sarcoma in a child with neurofibromatosis type 1.

Karen S Fernandez, Michelle L Turski, Avanthi Tayi Shah, Boris C Bastian, Andrew Horvai, Steven Hardee, E Alejandro Sweet-Cordero

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Karen S FernandezDivision of Hematology/Oncology, Valley Children's Hospital, Madera, California 93636, USA.
Michelle L TurskiMolecular Oncology Initiative, University of California, San Francisco, San Francisco, California 94158, USA.
Avanthi Tayi ShahDivision of Hematology and Oncology, Department of Pediatrics, University of California, San Francisco, San Francisco, California 94158, USA.
Boris C BastianDepartments of Dermatology and Pathology, University of California, San Francisco, San Francisco, California 94158, USA.
Andrew HorvaiDepartment of Pathology, University of California, San Francisco, San Francisco, California 94158, USA.
Steven HardeeDivision of Pathology, Valley Children's Hospital, Madera, California 93636, USA.
E Alejandro Sweet-CorderoDivision of Hematology and Oncology, Department of Pediatrics, University of California, San Francisco, San Francisco, California 94158, USA.ORCID 0000-0002-9787-9351
University of California, San Francisco · USChildren's Hospital Central California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report here on a case of Ewing sarcoma (ES) occurring in a child with neurofibromatosis type 1. The sarcoma had an EWSR1-ERG translocation as well as loss of the remaining wild-type allele of

Indexed as

Child, PreschoolFamilyFemaleHumansMutationNeurofibromatosis 1ras ProteinsSarcoma, Ewingras ProteinsEwing's sarcomamultiple cafe-au-lait spotsneurofibromas

Identifiers

PMID31645347
PMCPMC6824249
OpenAlexW2981771345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.